MUC1 and neoplasm: Cytosine-guanosine nucleotide (CpG) enhanced the antitumor effect of BCG HSP65 when anchored to tumor antigens Her2 [55] or tumor-associated antigen Mucin 1 (MUC1) [56,57], both expressed in melanoma cells.